Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01994317 · ClinicalTrials.gov registry record · NA

Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion

A NA study of Pregnancy, Unplanned, sponsored by Planned Parenthood League of Massachusetts.

Completed
Registry status
NA
Development phase
196
Enrollment target
1
Study location

NCT01994317: Completed NA study of Pregnancy, Unplanned, sponsored by Planned Parenthood League of Massachusetts.

NCT01994317 is a NA study of Pregnancy, Unplanned that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 196 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01994317, a NA study of Pregnancy, Unplanned, has completed, sponsored by Planned Parenthood League of Massachusetts.

COMPLETED
Registry status
NA
Development phase
196 participants
Enrollment target
1
Study location

Study Summary

This study aims to compare an algorithm for IV sedation dosing to the current standard of care in patients undergoing first trimester surgical abortion. The primary outcome is subjects' pain score with suction curettage on a 0-100 21-point scale. Secondary outcomes include pain scores with cervical dilation and 15 minutes post-procedure, subjective pain ratings, incidents of side effects and adverse events, the frequency of additional doses of medication, recovery room time, and physician assessment of and satisfaction with pain control. Investigators hypothesize that this algorithm will result in improved pain control, decreased frequency of additional medication doses, improved patient and physician satisfaction, without differences in side effects, adverse events or recovery room time.

Primary Outcome

Subjects' pain score with suction curettage on a 0-100 21-point scale

Conditions Studied

Interventions

  • OTHER Standard care
  • OTHER Algorithm

Study Locations (1)

Massachusetts

  • Planned Parenthood - Boston

Trial Details

FieldValue
Enrollment Target 196 participants
Start Date 2013-11
Est. Completion 2015-07
Phase NA

What the finished NCT01994317 record still lists

NCT01994317 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Pregnancy, Unplanned appearing as the primary indexed condition, and to 2 interventions - of which Standard care is the first listed.

NCT01994317 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01994317 about?

NCT01994317 is a clinical study titled "Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion". This study aims to compare an algorithm for IV sedation dosing to the current standard of care in patients undergoing first trimester surgical abortion. The primary outcome is subjects' pain score with suction curettage on a 0-100 21-point scale. Secondary outcomes include pain scores with cervical ...

What is the current status of trial NCT01994317?

This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2013-11. Estimated completion is 2015-07.

What conditions does trial NCT01994317 study?

This clinical trial studies the following conditions: Pregnancy, Unplanned.

What interventions are being tested in trial NCT01994317?

The interventions under investigation include: Standard care (OTHER), Algorithm (OTHER).

Who is sponsoring clinical trial NCT01994317?

This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01994317 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01994317's enrollment target sits among peer trials

196 567th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02822768 · 196 participants · NA

    Packing Versus no Packing for Cutaneous Abscess

  • NCT04250259 · 196 participants · Phase 2

    SAMe Trial for Patients With Alcoholic Cirrhosis

  • NCT05142592 · 196 participants · Phase 1

    Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

  • NCT05317832 · 196 participants · Phase 2

    Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01994317, the US trial registry maintained by the National Library of Medicine. NCT01994317 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.